• 1
    Fallowfield L, Ratcliffe D, Souhami RL. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer. 1997; 33: 22212229.
  • 2
    Siminoff LA, Zhang A, Colabianchi N, Saunders Sturm CM, Shen Q. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol. 2000; 18: 12031211.
  • 3
    Swanson GM, Ward A. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995; 87: 17471759.
  • 4
    Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott RJ. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999; 52: 11431156.
  • 5
    Primo L, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001; 19: 17281733.
  • 6
    Cook Gotay C. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med. 1991; 33: 569577.
  • 7
    Foley J, Moertel CG. Improving accrual into cancer clinical trials. J Cancer Educ. 1991; 6: 165173.
  • 8
    Winn R. Obstacles to the accrual of patients to clinical trials in the community setting. Semin Oncol. 1994; 21: 112117.
  • 9
    Slevin M, Mossman J, Bowling A, et al. Volunteers or victims: patients' views of randomised cancer clinical trials. Br J Cancer. 1995; 71: 12701274.
  • 10
    Tangrea J. Patient participation and compliance in cancer chemoprevention trials: issues and concerns. Proc Soc Exp Biol Med. 1997; 216: 260265.
  • 11
    Ellis P, Butow P, Tattersall MHN, Stewart M, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001; 19: 35543561.
  • 12
    Rubin H, Rubin I. Qualitative interviewing: the art of hearing data. Thousand Oaks, CA: Sage Publications, 1995.
  • 13
    Glaser B, Strauss A. Discovery of grounded theory. Chicago: Aldine, 1967.
  • 14
    Johansen M, Mayer KH, Hoover H. Obstacles to implementing cancer clinical trials. Semin Oncol Nurs. 1991; 7: 260267.
  • 15
    Hancock BW, Aitken M, Radstone C, Hudson GV. Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation Studies. BMJ. 1997; 314: 3637.
  • 16
    Joffe S, Francis Cook E, Cleary P, Clark J, Weeks J. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001; 358: 17721777.